326 related articles for article (PubMed ID: 36359260)
21. Causes of hyperhomocysteinemia and its pathological significance.
Kim J; Kim H; Roh H; Kwon Y
Arch Pharm Res; 2018 Apr; 41(4):372-383. PubMed ID: 29552692
[TBL] [Abstract][Full Text] [Related]
22. [Does magnetization transfer ratio (MTR) contribute to the diagnosis and differential diagnosis of the dementias?].
Hentschel F; Kreis M; Damian M; Krumm B
Rofo; 2004 Dec; 176(12):1743-9. PubMed ID: 15573284
[TBL] [Abstract][Full Text] [Related]
23. Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID).
Hainsworth AH; Yeo NE; Weekman EM; Wilcock DM
Biochim Biophys Acta; 2016 May; 1862(5):1008-17. PubMed ID: 26689889
[TBL] [Abstract][Full Text] [Related]
24. [Hyperhomocysteinemia in patients with dementia].
Graban A
Neurol Neurochir Pol; 2003; 37(4):879-87. PubMed ID: 14746246
[TBL] [Abstract][Full Text] [Related]
25. Hyperhomocysteinemia in dementia.
Leblhuber F; Walli J; Artner-Dworzak E; Vrecko K; Widner B; Reibnegger G; Fuchs D
J Neural Transm (Vienna); 2000; 107(12):1469-74. PubMed ID: 11458999
[TBL] [Abstract][Full Text] [Related]
26. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
27. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
28. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of hyperhomocysteinemia prevalence and its influence on the selected cognitive functions in patients with schizophrenia.
Trześniowska-Drukała B; Kalinowska S; Safranow K; Kłoda K; Misiak B; Samochowiec J
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109679. PubMed ID: 31254573
[TBL] [Abstract][Full Text] [Related]
30. [Homocysteine and dementia].
Kessler H; Bleich S; Falkai P; Supprian T
Fortschr Neurol Psychiatr; 2003 Mar; 71(3):150-6. PubMed ID: 12624852
[TBL] [Abstract][Full Text] [Related]
31. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.
Chan CC; Fage BA; Burton JK; Smailagic N; Gill SS; Herrmann N; Nikolaou V; Quinn TJ; Noel-Storr AH; Seitz DP
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011414. PubMed ID: 31521064
[TBL] [Abstract][Full Text] [Related]
32. Digit symbol substitution test score and hyperhomocysteinemia in older adults.
Hsu WC; Chu YC; Fung HC; Wai YY; Wang JJ; Lee JD; Chen YC
Medicine (Baltimore); 2016 Aug; 95(35):e4535. PubMed ID: 27583864
[TBL] [Abstract][Full Text] [Related]
33. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine and brain atrophy.
Sachdev PS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1152-61. PubMed ID: 16102882
[TBL] [Abstract][Full Text] [Related]
35. Association Between Cognitive Impairment and Vitamin B12, Folate, and Homocysteine Status in Elderly Adults: A Retrospective Study.
Baroni L; Bonetto C; Rizzo G; Bertola C; Caberlotto L; Bazzerla G
J Alzheimers Dis; 2019; 70(2):443-453. PubMed ID: 31177227
[TBL] [Abstract][Full Text] [Related]
36. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress.
Hoffman M
Med Hypotheses; 2011 Dec; 77(6):1088-93. PubMed ID: 21963358
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease and total plasma aminothiols.
McCaddon A; Hudson P; Hill D; Barber J; Lloyd A; Davies G; Regland B
Biol Psychiatry; 2003 Feb; 53(3):254-60. PubMed ID: 12559659
[TBL] [Abstract][Full Text] [Related]
38. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
[TBL] [Abstract][Full Text] [Related]
39. Homocysteine and cognitive function in the Sacramento Area Latino Study on Aging.
Miller JW; Green R; Ramos MI; Allen LH; Mungas DM; Jagust WJ; Haan MN
Am J Clin Nutr; 2003 Sep; 78(3):441-7. PubMed ID: 12936927
[TBL] [Abstract][Full Text] [Related]
40. Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period.
Tu MC; Huang CW; Chen NC; Chang WN; Lui CC; Chen CF; Chen C; Wang YL; Lin YT; Chang CC
Acta Neurol Taiwan; 2010 Sep; 19(3):168-77. PubMed ID: 20824536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
